Treatment of sickle-cell disease

Br J Haematol. 1974 Dec;28(4):437-44. doi: 10.1111/j.1365-2141.1974.tb06662.x.
No abstract available

MeSH terms

  • Anemia, Sickle Cell / complications
  • Anemia, Sickle Cell / physiopathology
  • Anemia, Sickle Cell / therapy*
  • Anesthesia
  • Anticoagulants / therapeutic use
  • Aspirin / therapeutic use
  • Bicarbonates / therapeutic use
  • Blood
  • Blood Flow Velocity
  • Blood Viscosity
  • Body Temperature
  • Bone Marrow Cells
  • Cyanates / therapeutic use
  • Female
  • Folic Acid / therapeutic use
  • Hemoglobin, Sickle / analysis
  • Hemolysis
  • Humans
  • Hydrogen-Ion Concentration
  • Hygiene
  • Infarction / etiology
  • Kidney Concentrating Ability
  • Leg Ulcer / etiology
  • Male
  • Maternal Mortality
  • Models, Structural
  • Pregnancy
  • Pregnancy Complications, Hematologic / therapy
  • Thrombophlebitis / etiology
  • Urea / therapeutic use

Substances

  • Anticoagulants
  • Bicarbonates
  • Cyanates
  • Hemoglobin, Sickle
  • Urea
  • Folic Acid
  • Aspirin